RxDoctor Payments Data

Cyril Goshima

Internal Medicine · Honolulu, HINPI 1588602130

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (59.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Gilead accounts for 77.3% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2019 at $15,235 and has fallen 98.0% since, to $300 in 2023. Among internal medicine clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,025in general payments, 2019–2025

Across 241 payments — averaging $78.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$15K
  • Viiv Healthcare Company$866
  • Merck$601
  • Janssen Scientific Affairs, LLC$401
  • AstraZeneca$351
  • Smith+Nephew$215
  • plus $2K from 19 others

What the payments were for

  • Speaking & faculty fees$11,25159%
  • Travel & lodging$1,95610%
  • Food & beverage$5,81231%
  • Education$60%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,025 in reported general payments places this provider in the 95th percentile of 655 internal medicine providers in Hawaii.

See all internal medicine providers in Hawaii

Other internal medicine in Honolulu

See the full list for Hawaii

Where these figures come from

Is this you, or does something look wrong? →